LINC00052

gene
On this page

Also known as FLJ31461

Summary

LINC00052 (long intergenic non-protein coding RNA 52, HGNC:26455) is a long non-coding RNA gene on chromosome 15q25.3.

Predicted to be located in membrane.

Source: NCBI Gene 145978 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26455
Approved symbolLINC00052
Namelong intergenic non-protein coding RNA 52
Location15q25.3
Locus typeRNA, long non-coding
StatusApproved
AliasesFLJ31461
Ensembl geneENSG00000259527
Ensembl biotypelncRNA
Entrez145978
RNAcentralURS000004E371 — lncRNA, 1786 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 lncRNA

ENST00000560153, ENST00000785746

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000560153 — 3 exons

ExonStartEnd
ENSE000025420198757771087577764
ENSE000041618498757807587579866
ENSE000041618508757692787577047

Expression profiles

Bgee: expression breadth broad, 21 present calls, max score 79.28.

FANTOM5 (CAGE): breadth broad, TPM avg 6.9623 / max 258.7318, expressed in 306 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1482686.9123306
1482670.050034

Top tissues by expression

167 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099179.28gold quality
ventricular zoneUBERON:000305357.89silver quality
mucosa of paranasal sinusUBERON:000503054.72gold quality
hindlimb stylopod muscleUBERON:000425253.95silver quality
adenohypophysisUBERON:000219651.91gold quality
buccal mucosa cellCL:000233651.85silver quality
skin of hipUBERON:000155449.77silver quality
muscle of legUBERON:000138349.61gold quality
pituitary glandUBERON:000000748.48gold quality
adrenal glandUBERON:000236947.64gold quality
gastrocnemiusUBERON:000138847.18gold quality
tibial nerveUBERON:000132345.29gold quality
adult mammalian kidneyUBERON:000008244.51silver quality
upper lobe of lungUBERON:000894844.16silver quality
cortex of kidneyUBERON:000122543.74silver quality
lower lobe of lungUBERON:000894943.59silver quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
omental fat padUBERON:001041442.78gold quality
vaginaUBERON:000099642.71silver quality
secondary oocyteCL:000065542.57gold quality
ovaryUBERON:000099242.53silver quality
peritoneumUBERON:000235842.11gold quality
bloodUBERON:000017842.09gold quality
forebrainUBERON:000189041.45gold quality
vastus lateralisUBERON:000137941.41gold quality
quadriceps femorisUBERON:000137741.37gold quality
prefrontal cortexUBERON:000045141.35gold quality
superficial temporal arteryUBERON:000161441.33gold quality
lungUBERON:000204841.31gold quality
brainUBERON:000095541.22gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.95

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 9)

  • LINC00052 could regulate NTRK3 expression by forming complementary base pairing with miR-128 and miR-485-3p to reduce the luciferase activity of NTRK3 3’UTR. (PMID:27351280)
  • High LINC00052 levels predict activation of HER3-mediated signaling, promoting breast cancer growth. (PMID:28036286)
  • Study found a positive relationship between LINC00052 and miR-101-3p, and a negative relationship between miR-101-3p and SOX9 in hepatocellular carcinoma (HCC) tissues. Besides, miR-101-3p was involved in LINC00052 inhibiting HCC cells proliferation and metastasis. At the molecular level, LINC00052 downgulated SOX9 to inhibit HCC cells proliferation and metastasis by interacting with miR-101-3p. (PMID:30098428)
  • our data indicated that the LINC00052 also remarkably suppressed pancreatic tumor growth via modulating miR-330-3p in vivo (PMID:30712321)
  • Long noncoding RNA LINC00052 suppressed the proliferation, migration and invasion of glioma cells by upregulating KLF6. (PMID:31210314)
  • tumor spheroids can induce changes in the transcriptome of cultured cells, including deregulation of linc00052 in breast cancer (PMID:31301772)
  • LINC00052 ameliorates acute kidney injury by sponging miR-532-3p and activating the Wnt signaling pathway. (PMID:33231561)
  • Long Non-Coding RNA LINC00052 Targets miR-548p/Notch2/Pyk2 to Modulate Tumor Budding and Metastasis of Human Breast Cancer. (PMID:35918619)
  • Decoding LINC00052 role in breast cancer by bioinformatic and experimental analyses. (PMID:38832821)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): methamphetamine-induced psychosis